Ainos announced that its VELDONA formulation has been granted an invention patent in Taiwan and has filed for global patent protection under the Patent Cooperation Treaty. This patent represents a significant milestone in the treatment and prevention of coronavirus infections. The patented technology, titled “METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION” with patent number TW202402785A, showcases a novel therapeutic approach using VELDONA as the primary ingredient, which we believe significantly enhances immune system function and effectively reduces the risk of coronavirus infections.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIMD:
- Ainos CEO ‘profoundly optimistic’ about what the future holds
- Ainos reports 79% identification accuracy of AI Nose
- Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety
- Ainos Secures Tech Boost, Expands Portfolio and Settles Debt
- Ainos concludes growth financing from Lind Partners